logo

BTO

John Hancock·NYSE
--
--(--)
--
--(--)
1.50 / 10
Underperform

BTO's fundamental health is concerning, scoring only 1.5/10. Key weaknesses include a negative rate of return on total assets (-10.08%) and an annualized return of -20.16%, both in the lowest performance group. Although the fixed assets turnover ratio is high at 1031.01, indicating efficient fixed asset utilization, other metrics like diluted earnings per share growth (-14.08% YoY) and current asset ratios do not compensate for the losses. Overall, the fundamental profile argues for caution.

Fundamental(1.5)SentimentTechnical

Analysis Checks(1/7)

Current liabilities / Total liabilities (%)
Value52.15
Score1/3
Weight16.12%
1M Return1.49%
Basic earnings per share (YoY growth rate %)
Value103.89
Score1/3
Weight12.39%
1M Return1.18%
Rate of return on total assets (%)
Value-10.08
Score1/3
Weight14.75%
1M Return1.42%
Fixed assets turnover ratio
Value1031.01
Score2/3
Weight13.09%
1M Return1.25%
Annualized return on total assets (%)
Value-20.16
Score1/3
Weight14.75%
1M Return1.42%
Diluted earnings per share (YoY growth rate %)
Value-14.08
Score1/3
Weight13.17%
1M Return1.22%
Current assets / Total assets (%)
Value47.90
Score1/3
Weight15.72%
1M Return1.44%
Is BTO undervalued or overvalued?
  • BTO scores 1.50/10 on fundamentals and holds a Premium valuation at present. Backed by its 0.09% ROE, 593.63% net margin, 5.01 P/E ratio, 1.17 P/B ratio, and 14.52% earnings growth, these metrics solidify its Underperform investment rating.